Krishna Institute of Medical Sciences Limited (KIMS) has reported raising ₹150 crore as upfront warrant subscription money during the second quarter of the financial year 2027 (Q2FY27), which ended September 30, 2026. The company received this amount from the preferential issue of warrants. No funds were utilized towards the stated objects of the issue during the quarter, with the balance of ₹450 crore yet to be received upon the exercise and conversion of warrants.
Funds Raised via Preferential Issue
Krishna Institute of Medical Sciences Limited (KIMS) has disclosed the receipt of ₹150 crore as upfront warrant subscription money during the second quarter of the financial year 2027 (Q2FY27). This financial inflow stems from a preferential issue of warrants, with the total issue size aggregating to ₹600 crore.
Status of Fund Utilization
For the quarter ended September 30, 2026, KIMS Hospitals did not utilize any funds towards the stated objects of the issue. Consequently, the utilization of the issue proceeds remained nil for Q2FY27. The company is awaiting the balance amount of ₹450 crore, which is expected upon the exercise and conversion of the warrants. The allottees have a period of 18 months from the date of allotment (August 19, 2026), extending up to February 18, 2028, to exercise this option.
Deployment of Unutilized Proceeds
As of September 30, 2026, the unutilized net proceeds amounting to ₹149.99 crore were temporarily deployed in short-term instruments. These include ₹99.99 crore in ICICI Prudential Liquid Fund – Direct Growth and ₹50.00 crore in Nippon India Money Market Fund – Direct Growth. An additional ₹0.01 crore was held in a share capital account with Kotak Mahindra Bank. The total market value of these investments was reported as ₹150.96 crore.
Objects of the Issue
The original cost for the objects of the issue was detailed as follows: ₹260.00 crore for repayment, prepayment of outstanding borrowings, and ₹190.00 crore for investment into subsidiaries for repayment or prepayment of their borrowings. An amount of ₹150.00 crore was allocated for General Corporate Purpose, bringing the total to ₹600.00 crore. The monitoring agency confirmed that utilization for all these objects was nil during the quarter.
Source: BSE
